NuWays AG: Nynomic AG | Rating: BUY
Original-Research: Nynomic AG - von NuWays AG
Einstufung von NuWays AG zu Nynomic AG
Unternehmen: Nynomic AG
ISIN: DE000A0MSN11
Anlass der Studie: Update
Empfehlung: BUY
seit: 18.12.2023
Kursziel: € 54
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung:
Analyst: Christian Sandherr
Bolt-on acquisition with high synergy potential; chg.
Topic: Nynomic announced the 100% acquisition of art photonic (13th pillar of the Nynomic group), which should be highly value accretive during the coming years thanks to significant synergy potential.
In detail, art photonic is a Berlin-based expert in the development and production of highly specialized fiber optic cables used for optical measurement technology with a focus on mid-infrared (MIR) wavelength, making it highly compatible with the the recently acquired NLIR (early Oct.). Its products enable ultra-fast transmission of light to the measurement point and back to the sensor to process the received data. Both acquisitions support Nynomic's strategy to bring MIR in a scalable way into production processes integrated into stationary machines, production plants, commercial vehicles and similar, thus expanding Nynomic's future solution portfolio.
In 2023e, art photonics is seen to generate some € 4m sales with an EBIT margin of roughly 10% (eNuW). Thanks to significant cross-selling opportunities across Nynomic’s broad customer base, we expect art photonic’s annual sales growth potential to be at around 20% for the next three to four years. The resulting positive operating leverage should quickly enable EBIT margins of >15%, in our view. While the purchase price was not disclosed, we expect it to be in line with Nynomic’s recent acquisitions, i.e. ~1x EV/sales, or € 4m in the case of art photonics, making it a clearly value accretive deal.
Additional acquisitions to follow in H1 2024e. Carried by its inherently cash flow generating business model, the € 18.9m capital increase in May and in line with its buy and build strategy, Nynomic looks set to acquire 1-2, potentially also larger targets with up to € 20m sales during FY 2024e.
Further positive newsflow to stem from a strong Q4 and a continued strong momentum throughout 2024e. Following solid 9M results with € 83m sales and a 10% EBIT margin, Nynomic looks set to report a disproportionally strong Q4 due to confirmed call-off dates of formerly delayed orders, several new projects within structurally growing markets. Q4 sales should come in at € 37.6m (+14% yoy, eNuW) with an EBIT margin of 19.7% (eNuW). With several products (e.g. Spectral Engines) beginning to gain traction and structurally growing demand for existing solutions, organic sales growth during the next years should exceed 10% (eNuW).
BUY with an unchanged € 54 PT based on DCF.
Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28555.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++
-------------------übermittelt durch die EQS Group AG.-------------------
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.